Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frontal EEG Spectral Features with Remimazolam vs Propofol in Hip Surgery
ChiCTR2100054101Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remimazolam and propofol in hip fracture and hip osteoarthritis (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Spectral features of frontal electroencephalogram and Changes of EEG power before and after anesthesia. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hip fracturehip osteoarthritis
Beyond the preview
Go deeper on ChiCTR2100054101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054101.